SOFIE CO.
Doing business as IBA MOLECULAR
- DULLES, VA 20166-2499
- sofie.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $42.2M
- Awards on record
- 89
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
SOFIE CO. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About SOFIE CO.
- Headquarters
- DULLES, VA 20166-2499
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIJV1AHJHGUGG3
- CAGE09QR8
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $42.2M
- Awards on record
- 89
- Top funding agencies
- Department of Veterans Affairs · Defense Health Agency · Department of the Army
25 most recent of 89 awards
36C25027P0004
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)PET MRI PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $557.7K
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
36C24825P0009
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AMYLOID FLORBETABEN INJECTIONS RADIOPHARMACEUTICAL
Department of Veterans Affairs
- Obligated
- $282.2K
- Period of performance
- Oct 1, 2024 – Sep 30, 2027
36C25725P0020
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $694.7K
- Period of performance
- Oct 1, 2024 – Sep 30, 2027
36C25924P0003
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)PET/CT RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $5.1M
- Period of performance
- Oct 1, 2023 – Sep 30, 2027
36C26124P0052
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)PET RADIOPHAMACEUTICALS
Department of Veterans Affairs
- Obligated
- $798.4K
- Period of performance
- Oct 1, 2023 – Sep 30, 2027
36C25526N0392
Recompete 6–12 mo: Potential end Aug 31, 2027 (9 months away)ADD MAXIMUM QUANTITIES LIMITS TO IDC CONTRACT.
Department of Veterans Affairs
- Obligated
- $357.1K
- Period of performance
- Sep 1, 2026 – Aug 31, 2027
36C24422P0612
Recompete 6–12 mo: Potential end Jun 29, 2027 (7 months away)F-18 RADIOPHARMACY
Department of Veterans Affairs
- Obligated
- $1.3M
- Period of performance
- Jun 30, 2022 – Jun 29, 2027
36C25526N0245
Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)PYLARIFY F-18 DCFPYL
Department of Veterans Affairs
- Obligated
- $1.2M
- Period of performance
- Jun 1, 2026 – May 31, 2027
HT001426FE062
Recompete 6–12 mo: Potential end May 26, 2027 (6 months away)ACQUISITION OF NEURACEQ (FLORBETABEN F18).
Department of Defense · Defense Health Agency
- Obligated
- $244.6K
- Period of performance
- May 26, 2026 – May 26, 2027
36C24424P0468
Recompete < 6 mo: Potential end Apr 30, 2027 (5 months away)FDG & NEURACEQ RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $761.3K
- Period of performance
- May 1, 2024 – Apr 30, 2027
36C24226N0463
Recompete < 6 mo: Potential end Apr 14, 2027 (5 months away)PET RADIOPHARMACEUTICALS FOR BUFFALO VA MEDICAL CENTER.
Department of Veterans Affairs
- Obligated
- $624K
- Period of performance
- Apr 15, 2026 – Apr 14, 2027
36C24126P0008
Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)NEURACEQ
Department of Veterans Affairs
- Obligated
- $279.5K
- Period of performance
- Oct 3, 2025 – Mar 31, 2027
36C24226N0388
Recompete < 6 mo: Potential end Mar 14, 2027 (4 months away)POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS.
Department of Veterans Affairs
- Obligated
- $830.8K
- Period of performance
- Mar 15, 2026 – Mar 14, 2027
36C25626N0329
Recompete < 6 mo: Potential end Feb 28, 2027 (3 months away)RADIOACTIVE ISOTOPES PET TRACER IDC ORDERING YEAR THREE FOR MEDVAMC
Department of Veterans Affairs
- Obligated
- $339.6K
- Period of performance
- Jan 22, 2026 – Feb 28, 2027
36C25026P0310
Recompete < 6 mo: Potential end Jan 19, 2027 (2 months away)KENT VA - PET RADIOPHARMACEUTICAL
Department of Veterans Affairs
- Obligated
- $347K
- Period of performance
- Jan 20, 2026 – Jan 19, 2027
HT001426FE014
Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)BPA CALL ORDER FOR RADIOACTIVE PHARMACEUTICALS REQUIRED FOR POSITRON EMISSION TOMOGRAPHY (PET).
Department of Defense · Defense Health Agency
- Obligated
- $249.8K
- Period of performance
- Jan 15, 2026 – Jan 14, 2027
36C25526N0118
Recompete < 6 mo: Potential end Jan 8, 2027 (1 month away)PET-CT DOSE KC VAMC
Department of Veterans Affairs
- Obligated
- $252.8K
- Period of performance
- Jan 12, 2026 – Jan 8, 2027
HT009026FG0210049
Completed: Period of performance ended Sep 30, 2026RADIO-PHARMACEUTICAL FOR PATIENT CARE.
Department of Defense · Defense Health Agency
- Obligated
- $21.9K
- Period of performance
- Feb 4, 2026 – Sep 30, 2026
HT009026FG0110043
Completed: Period of performance ended Sep 30, 2026RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT.
Department of Defense · Defense Health Agency
- Obligated
- $10.8K
- Period of performance
- Dec 23, 2025 – Sep 30, 2026
HT009026FG1210062
Completed: Period of performance ended Sep 30, 2026RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT
Department of Defense · Defense Health Agency
- Obligated
- $25.3K
- Period of performance
- Dec 2, 2025 – Sep 30, 2026
HT009026FG1110036
Completed: Period of performance ended Sep 30, 2026PHARMACEUTICALS NEEDED FOR PATIENT CARE.
Department of Defense · Defense Health Agency
- Obligated
- $36.1K
- Period of performance
- Nov 4, 2025 – Sep 30, 2026
36C25026P0012
Completed: Period of performance ended Sep 30, 2026PET MRI RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $578.6K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
W81K0025PA260
Completed: Period of performance ended Sep 30, 2026RADIOPHARMACEUTICALS REQUIREMENT IS NECESSARY TO SUPPORT THE DEPARTMENT OF RADIOLOGY, NUCLEAR MEDICINE CLINIC.
Department of Defense · Department of the Army
- Obligated
- $187.9K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C25625N0859
Completed: Period of performance ended Sep 30, 2026PYLARIFY PIFLUFOLASTAT F18
Department of Veterans Affairs
- Obligated
- $1.5M
- Period of performance
- Sep 1, 2025 – Sep 30, 2026
36C25026N0023
Completed: Period of performance ended Sep 30, 2026EXERCISING THE ORDERING PERIOD 5
Department of Veterans Affairs
- Obligated
- $508.3K
- Period of performance
- Oct 1, 2021 – Sep 30, 2026
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C25027P0004 PET MRI PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $557.7K | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C25027P0004Bid team for the recompete of award 36C25027P0004 |
36C24825P0009 AMYLOID FLORBETABEN INJECTIONS RADIOPHARMACEUTICAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $282.2K | Oct 1, 2024 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C24825P0009Bid team for the recompete of award 36C24825P0009 |
36C25725P0020 POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $694.7K | Oct 1, 2024 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C25725P0020Bid team for the recompete of award 36C25725P0020 |
36C25924P0003 PET/CT RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $5.1M | Oct 1, 2023 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C25924P0003Bid team for the recompete of award 36C25924P0003 |
36C26124P0052 PET RADIOPHAMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $798.4K | Oct 1, 2023 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 36C26124P0052Bid team for the recompete of award 36C26124P0052 |
36C25526N0392 under 36C25522D0055 ADD MAXIMUM QUANTITIES LIMITS TO IDC CONTRACT. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $357.1K | Sep 1, 2026 – Aug 31, 2027 | Recompete 6–12 mo: Potential end Aug 31, 2027 (9 months away)AI brief for award 36C25526N0392Bid team for the recompete of award 36C25526N0392 |
36C24422P0612 F-18 RADIOPHARMACY | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.3M | Jun 30, 2022 – Jun 29, 2027 | Recompete 6–12 mo: Potential end Jun 29, 2027 (7 months away)AI brief for award 36C24422P0612Bid team for the recompete of award 36C24422P0612 |
36C25526N0245 under 36C25524D0411 PYLARIFY F-18 DCFPYL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.2M | Jun 1, 2026 – May 31, 2027 | Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)AI brief for award 36C25526N0245Bid team for the recompete of award 36C25526N0245 |
HT001426FE062 under HT001424A0002 ACQUISITION OF NEURACEQ (FLORBETABEN F18). | Department of Defense · Defense Health Agency | 325412 · 6505DRUGS AND BIOLOGICALS | $244.6K | May 26, 2026 – May 26, 2027 | Recompete 6–12 mo: Potential end May 26, 2027 (6 months away)AI brief for award HT001426FE062Bid team for the recompete of award HT001426FE062 |
36C24424P0468 FDG & NEURACEQ RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $761.3K | May 1, 2024 – Apr 30, 2027 | Recompete < 6 mo: Potential end Apr 30, 2027 (5 months away)AI brief for award 36C24424P0468Bid team for the recompete of award 36C24424P0468 |
36C24226N0463 under 36C24225D0064 PET RADIOPHARMACEUTICALS FOR BUFFALO VA MEDICAL CENTER. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $624K | Apr 15, 2026 – Apr 14, 2027 | Recompete < 6 mo: Potential end Apr 14, 2027 (5 months away)AI brief for award 36C24226N0463Bid team for the recompete of award 36C24226N0463 |
36C24126P0008 NEURACEQ | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $279.5K | Oct 3, 2025 – Mar 31, 2027 | Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)AI brief for award 36C24126P0008Bid team for the recompete of award 36C24126P0008 |
36C24226N0388 under 36C24226D0040 POSITRON EMISSION TOMOGRAPHY (PET) RADIOPHARMACEUTICALS. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $830.8K | Mar 15, 2026 – Mar 14, 2027 | Recompete < 6 mo: Potential end Mar 14, 2027 (4 months away)AI brief for award 36C24226N0388Bid team for the recompete of award 36C24226N0388 |
36C25626N0329 under 36C25624D0046 RADIOACTIVE ISOTOPES PET TRACER IDC ORDERING YEAR THREE FOR MEDVAMC | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $339.6K | Jan 22, 2026 – Feb 28, 2027 | Recompete < 6 mo: Potential end Feb 28, 2027 (3 months away)AI brief for award 36C25626N0329Bid team for the recompete of award 36C25626N0329 |
36C25026P0310 KENT VA - PET RADIOPHARMACEUTICAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $347K | Jan 20, 2026 – Jan 19, 2027 | Recompete < 6 mo: Potential end Jan 19, 2027 (2 months away)AI brief for award 36C25026P0310Bid team for the recompete of award 36C25026P0310 |
HT001426FE014 under HT001424A0002 BPA CALL ORDER FOR RADIOACTIVE PHARMACEUTICALS REQUIRED FOR POSITRON EMISSION TOMOGRAPHY (PET). | Department of Defense · Defense Health Agency | 325412 · 6505DRUGS AND BIOLOGICALS | $249.8K | Jan 15, 2026 – Jan 14, 2027 | Recompete < 6 mo: Potential end Jan 14, 2027 (2 months away)AI brief for award HT001426FE014Bid team for the recompete of award HT001426FE014 |
36C25526N0118 under 36C25526D0024 PET-CT DOSE KC VAMC | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $252.8K | Jan 12, 2026 – Jan 8, 2027 | Recompete < 6 mo: Potential end Jan 8, 2027 (1 month away)AI brief for award 36C25526N0118Bid team for the recompete of award 36C25526N0118 |
HT009026FG0210049 under HT001424A0002 RADIO-PHARMACEUTICAL FOR PATIENT CARE. | Department of Defense · Defense Health Agency | 325412 · 6506BLOOD AND BLOOD PRODUCTS | $21.9K | Feb 4, 2026 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HT009026FG0110043 under HT001424A0002 RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT. | Department of Defense · Defense Health Agency | 325412 · 6505DRUGS AND BIOLOGICALS | $10.8K | Dec 23, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HT009026FG1210062 under HT001424A0002 RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT | Department of Defense · Defense Health Agency | 325412 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $25.3K | Dec 2, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HT009026FG1110036 under HT001424A0002 PHARMACEUTICALS NEEDED FOR PATIENT CARE. | Department of Defense · Defense Health Agency | 325412 · 6506BLOOD AND BLOOD PRODUCTS | $36.1K | Nov 4, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C25026P0012 PET MRI RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $578.6K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
W81K0025PA260 RADIOPHARMACEUTICALS REQUIREMENT IS NECESSARY TO SUPPORT THE DEPARTMENT OF RADIOLOGY, NUCLEAR MEDICINE CLINIC. | Department of Defense · Department of the Army | 325412 · 6505DRUGS AND BIOLOGICALS | $187.9K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C25625N0859 under 36C25624D0071 PYLARIFY PIFLUFOLASTAT F18 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $1.5M | Sep 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C25026N0023 under 36C25022D0006 EXERCISING THE ORDERING PERIOD 5 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $508.3K | Oct 1, 2021 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- Q522MEDICAL- RADIOLOGY
- Q527MEDICAL- NUCLEAR MEDICINE
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with SOFIE CO.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
